1
|
Yang Y, Feng Z, Luo YH, Chen JM, Zhang Y, Liao YJ, Jiang H, Long Y, Wei B. Exercise-Induced Central Fatigue: Biomarkers, and Non-Medicinal Interventions. Aging Dis 2024:AD.2024.0567. [PMID: 39012671 DOI: 10.14336/ad.2024.0567] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2024] [Accepted: 06/27/2024] [Indexed: 07/17/2024] Open
Abstract
Fatigue, commonly experienced in daily life, is a feeling of extreme tiredness, shortage or lack of energy, exhaustion, and difficulty in performing voluntary tasks. Central fatigue, defined as a progressive failure to voluntarily activate the muscle, is typically linked to moderate- or light-intensity exercise. However, in some instances, high-intensity exercise can also trigger the onset of central fatigue. Exercise-induced central fatigue often precedes the decline in physical performance in well-trained athletes. This leads to a reduction in nerve impulses, decreased neuronal excitability, and an imbalance in brain homeostasis, all of which can adversely impact an athlete's performance and the longevity of their sports career. Therefore, implementing strategies to delay the onset of exercise-induced central fatigue is vital for enhancing athletic performance and safeguarding athletes from the debilitating effects of fatigue. In this review, we discuss the structural basis, measurement methods, and biomarkers of exercise-induced central fatigue. Furthermore, we propose non-pharmacological interventions to mitigate its effects, which can potentially foster improvements in athletes' performances in a healthful and sustainable manner.
Collapse
Affiliation(s)
- Ying Yang
- Institute of Translational Medicine, School of Basic Medical, Department of Special Medicine, School of Public Health, Hengyang Medical College, University of South China, Hengyang, 421001, China
| | - Zhi Feng
- Institute of Translational Medicine, School of Basic Medical, Department of Special Medicine, School of Public Health, Hengyang Medical College, University of South China, Hengyang, 421001, China
| | - Yu-Hang Luo
- Institute of Translational Medicine, School of Basic Medical, Department of Special Medicine, School of Public Health, Hengyang Medical College, University of South China, Hengyang, 421001, China
| | - Jue-Miao Chen
- Institute of Translational Medicine, School of Basic Medical, Department of Special Medicine, School of Public Health, Hengyang Medical College, University of South China, Hengyang, 421001, China
| | - Yu Zhang
- Institute of Translational Medicine, School of Basic Medical, Department of Special Medicine, School of Public Health, Hengyang Medical College, University of South China, Hengyang, 421001, China
| | - Yi-Jun Liao
- Institute of Translational Medicine, School of Basic Medical, Department of Special Medicine, School of Public Health, Hengyang Medical College, University of South China, Hengyang, 421001, China
| | - Hui Jiang
- Institute of Translational Medicine, School of Basic Medical, Department of Special Medicine, School of Public Health, Hengyang Medical College, University of South China, Hengyang, 421001, China
| | - Yinxi Long
- Department of Neurology, Affiliated Hengyang Hospital of Hunan Normal University &;amp Hengyang Central Hospital, Hengyang, 421001, China
| | - Bo Wei
- Institute of Translational Medicine, School of Basic Medical, Department of Special Medicine, School of Public Health, Hengyang Medical College, University of South China, Hengyang, 421001, China
| |
Collapse
|
2
|
Smith MA, Schmidt KT, Sharp JL, Pearson T, Davis AL, Gibson AN, Potter KM. Lack of evidence for positive reinforcing and prosocial effects of MDMA in pair-housed male and female rats. Eur J Pharmacol 2021; 913:174646. [PMID: 34800468 DOI: 10.1016/j.ejphar.2021.174646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2021] [Revised: 11/14/2021] [Accepted: 11/15/2021] [Indexed: 10/19/2022]
Abstract
3,4-Methylenedioxymethamphetamine (MDMA) is classified as an entactogen, producing feelings of emotional openness and relatedness. One unique feature of MDMA is that people tend to selectively take this drug in social and/or intimate situations. Although MDMA is recognized as having abuse liability, preclinical studies report that it has weak reinforcing effects in animals. The objective of this study was to characterize the positive reinforcing and prosocial effects of MDMA in a translational model of the social environment in which two rats have simultaneous and contingent access to MDMA in close physical proximity. To this end, MDMA self-administration was examined on both fixed and progressive ratio schedules of reinforcement in six groups of rats: (1) isolated males, (2) isolated females, (3) male-male dyads, (4) female-female dyads, (5) male-female dyads, and (6) female-male dyads. For pair-housed rats, data from both rats were analyzed. Next, social preferences were examined in a partner preference test. MDMA failed to produce positive reinforcing effects under all conditions examined. Across a 30-fold dose range (0.01-1.0 mg/kg/infusion), MDMA did not maintain higher responding than saline on both schedules of reinforcement and in all groups tested. In partner preference tests, a history of shared exposure to MDMA did not establish a social preference, and acute administration of MDMA failed to establish a preference for another MDMA-treated rat. These data suggest that social contact does not increase the positive reinforcing effects of MDMA in rats, and that neither contingent nor noncontingent MDMA administration establishes a social preference in rats.
Collapse
Affiliation(s)
- Mark A Smith
- Department of Psychology and Program in Neuroscience, Davidson College, Davidson, NC, USA.
| | - Karl T Schmidt
- Department of Psychology and Program in Neuroscience, Davidson College, Davidson, NC, USA
| | - Jessica L Sharp
- Department of Psychology and Program in Neuroscience, Davidson College, Davidson, NC, USA
| | - Tallia Pearson
- Department of Psychology and Program in Neuroscience, Davidson College, Davidson, NC, USA
| | - Anna L Davis
- Department of Psychology and Program in Neuroscience, Davidson College, Davidson, NC, USA
| | - Abigail N Gibson
- Department of Psychology and Program in Neuroscience, Davidson College, Davidson, NC, USA
| | - Kenzie M Potter
- Department of Psychology and Program in Neuroscience, Davidson College, Davidson, NC, USA
| |
Collapse
|
3
|
Scott SN, Garcia R, Powell GL, Doyle SM, Ruscitti B, Le T, Esquer A, Blattner KM, Blass BE, Neisewander JL. 5-HT 1B receptor agonist attenuates cocaine self-administration after protracted abstinence and relapse in rats. J Psychopharmacol 2021; 35:1216-1225. [PMID: 34049460 DOI: 10.1177/02698811211019279] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND The 5-HT1B receptor (5-HT1BR) agonist, CP94253, enhances cocaine intake during maintenance of self-administration (SA) but attenuates intake after 21 days of forced abstinence in male rats. AIMS We examined whether CP94253 attenuates cocaine intake in female rats after a period of abstinence, and if these attenuating effects persist or revert to enhancing cocaine intake during resumption (i.e. relapse) of daily cocaine SA. METHODS Male and female rats trained to lever press on a fixed ratio 5 schedule of cocaine reinforcement underwent ⩾21 days of forced abstinence. They were then tested for the effects of CP94253 (5.6 mg/kg, SC) or vehicle on cocaine SA. During the test session, rats had 1-h access to the training dose of cocaine (0.75 mg/kg, IV) followed by 1-h access to a lower cocaine dose (0.075 mg/kg, IV). Rats then resumed cocaine SA for 15 days to mimic relapse and were retested as done previously. Subsequently, rats underwent abstinence again (21-60 days) and were tested for CP94253 effects on locomotion and cue reactivity (i.e. responding for light/tone cues previously paired with cocaine infusions). RESULTS Regardless of sex, CP94253 decreased cocaine intake after abstinence and during resumption of SA and decreased cue reactivity while having no effect on locomotion. CONCLUSIONS CP94253 decreases cocaine intake and cocaine seeking in both males and females even after resumption of cocaine SA. These findings suggest that the inhibitory effects of CP94253 observed after abstinence are long-lasting, and therefore, 5-HT1BR agonists may have clinical efficacy as anti-relapse medications for cocaine use disorders.
Collapse
Affiliation(s)
- Samantha N Scott
- School of Life Sciences, Arizona State University, Tempe, AZ, USA
| | - Raul Garcia
- School of Life Sciences, Arizona State University, Tempe, AZ, USA
| | - Gregory L Powell
- School of Life Sciences, Arizona State University, Tempe, AZ, USA
| | - Sophia M Doyle
- School of Life Sciences, Arizona State University, Tempe, AZ, USA
| | - Brielle Ruscitti
- School of Life Sciences, Arizona State University, Tempe, AZ, USA
| | - Tien Le
- School of Life Sciences, Arizona State University, Tempe, AZ, USA.,School of Biological Systems and Health Engineering, Arizona State University, Tempe, AZ, USA
| | - Aracely Esquer
- School of Life Sciences, Arizona State University, Tempe, AZ, USA
| | - Kevin M Blattner
- Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, PA, USA
| | - Benjamin E Blass
- Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, PA, USA
| | | |
Collapse
|
4
|
Schenk S, Highgate Q. Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse. J Neurochem 2021; 157:1714-1724. [PMID: 33711169 DOI: 10.1111/jnc.15348] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Revised: 03/08/2021] [Accepted: 03/09/2021] [Indexed: 12/21/2022]
Abstract
Methylenedioxymethamphetamine (MDMA) is an amphetamine analogue that preferentially stimulates the release of serotonin (5HT) and results in relatively small increases in synaptic dopamine (DA). The ratio of drug-stimulated increases in synaptic DA, relative to 5HT, predicts the abuse liability; drugs with higher DA:5HT ratios are more likely to be abused. Nonetheless, MDMA is a drug that is misused. Clinical and preclinical studies have suggested that repeated MDMA exposure produces neuroadaptive responses in both 5HT and DA neurotransmission that might explain the development and maintenance of MDMA self-administration in some laboratory animals and the development of a substance use disorder in some humans. In this paper, we describe the research that has demonstrated an inhibitory effect of 5HT on the acquisition of MDMA self-administration and the critical role of DA in the maintenance of MDMA self-administration in laboratory animals. We then describe the circuitry and 5HT receptors that are positioned to modulate DA activity and review the limited research on the effects of MDMA exposure on these receptor mechanisms.
Collapse
Affiliation(s)
- Susan Schenk
- School of Psychology, Victoria University of Wellington, Wellington, New Zealand
| | - Quenten Highgate
- School of Psychology, Victoria University of Wellington, Wellington, New Zealand
| |
Collapse
|
5
|
Fonseca DA, Teixeira C, Carvalho F, Fernandes E, Antunes PE, Antunes MJ, Cotrim MD. MDMA modulates 5-HT1-mediated contractile response of the human internal thoracic artery in vitro. Toxicol In Vitro 2019; 55:15-17. [PMID: 30448555 DOI: 10.1016/j.tiv.2018.11.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2018] [Revised: 10/29/2018] [Accepted: 11/14/2018] [Indexed: 11/24/2022]
|
6
|
Highgate Q, Schenk S. Comparison of the effects of abstinence on MDMA and cocaine self-administration in rats. Psychopharmacology (Berl) 2018; 235:3233-3241. [PMID: 30209532 DOI: 10.1007/s00213-018-5026-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/13/2018] [Accepted: 09/04/2018] [Indexed: 12/16/2022]
Abstract
RATIONALE 3,4-Methylenedioxymethamphetamine (MDMA) preferentially increases synaptic serotonin (5HT). This response was attenuated following repeated exposure but there was recovery as a result of abstinence. Effects of abstinence on self-administration of many drugs have been documented but the impact on MDMA self-administration is unknown. OBJECTIVE This study compared the effects of abstinence on MDMA and cocaine self-administration. METHODS Six-hour daily MDMA or cocaine sessions were conducted until a total of 350 mg/kg had been self-administered. Following this, rats were randomly assigned to either a 0- or 14-day abstinence group. Self-administration testing then continued for an additional 7 days. RESULTS The latency to self-administer 350 mg/kg was shorter for rats that self-administered cocaine. The temporal distribution of responding within each test session also differed; MDMA self-administration was high during the first hour of each session, and decreased during subsequent hours, whereas cocaine self-administration was evenly distributed throughout each hour of the session. Abstinence decreased MDMA but not cocaine self-administration. CONCLUSIONS The selective reduction of MDMA self-administration following abstinence is consistent with the idea that MDMA-stimulated 5-HT release is inhibitory to MDMA self-administration.
Collapse
Affiliation(s)
- Quenten Highgate
- School of Psychology, Victoria University of Wellington, Wellington, 6011, New Zealand
| | - Susan Schenk
- School of Psychology, Victoria University of Wellington, Wellington, 6011, New Zealand.
| |
Collapse
|